SHRM appoints former Red Bull Canada president to Special Advisory Committee New member’s background in heavily regulated industries coupled with experience in CPG space provides great complement Effective immediately, Champignon common shares being traded on OTCQB Venture Market Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to applying novel and … Continue reading “Champignon Brands Inc.’s (CSE: SHRM) (OTC: SHRMF) (FWB: 496) New Committee Member Strengthens Compentencies”
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that it has been chosen as the Headline Partner for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Chosen as Headline Partner for PSYCH: The Psychedelics Symposium”
SHRM to acquire AltMed Capital Corp, a Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer Champignon to roll out five unique ketamine clinics across Florida, California and the U.S. Eastern seaboard CRTCE is only center worldwide to demonstrate rapid onset treatments improve health outcomes within weeks Champignon Brands Inc. (CSE: SHRM) … Continue reading “Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Announces Acquisition of Canada’s Only Approved Psychedelic Medicine Clinic”
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market”
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company that is advancing its clinical pipeline through its ongoing TBI/PTSD-focused preclinical studies at the University of Miami’s Miller School of Medicine, today announced that its research partner and lead investigator, Dr. Michael Hoffer, has obtained a sustainable supply of psilocybin under a … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Research Partner Secures Steady Psilocybin Supply for Clinical Studies”
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility”
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, this morning announced the appointment of the former President of Red Bull Canada, Mr. Jim Bailey, to its Special … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Names New Member to Special Advisory Committee”
Dedicated to the health-conscious consumer Expanded preclinical trial pipeline by entering into definitive agreement to acquire Tassili Life Sciences Corp Expanding brand into alternative medicine by entering into a definitive agreement to acquire Novoformulations Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to the distribution of artisanal medicinal mushroom-infused products, … Continue reading “Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Reach into Preclinical Trials, Alternative Medicine”
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accelerate its advancements within the psychedelic medicine arena. On Thursday, Champignon Brands announced its plans to acquire … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire AltMed Capital Corp.”
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human-optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, offers a timely line of organic, non-GMO and vegan-certified products. In 2019, Johns Hopkins launched a center for psychedelic research … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Aims to Support Mental Health, Develop Improved Treatments Using Psilocybin Mushrooms”
